111 related articles for article (PubMed ID: 26133942)
21. Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013.
Qian ZJ; Jin MC; Meister KD; Megwalu UC
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):617-623. PubMed ID: 31120475
[TBL] [Abstract][Full Text] [Related]
22. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
[TBL] [Abstract][Full Text] [Related]
23. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
[TBL] [Abstract][Full Text] [Related]
24. Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.
Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; Hatzipantelis E; Stiakaki E; Dana H; Tragiannidis A; Bouka E; Antunes L; Bastos J; Coza D; Demetriou A; Agius D; Eser S; Gheorghiu R; Šekerija M; Trojanowski M; Žagar T; Zborovskaya A; Ryzhov A; Dessypris N; Morgenstern D; Petridou ET
Eur J Cancer; 2018 Jun; 96():44-53. PubMed ID: 29673989
[TBL] [Abstract][Full Text] [Related]
25. The International Neuroblastoma Pathology Classification (the Shimada system).
Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
[TBL] [Abstract][Full Text] [Related]
26. Incidence, survival, and prevalence of neuroendocrine tumors versus neuroblastoma in children and young adults: nine standard SEER registries, 1975-2006.
Navalkele P; O'Dorisio MS; O'Dorisio TM; Zamba GK; Lynch CF
Pediatr Blood Cancer; 2011 Jan; 56(1):50-7. PubMed ID: 21108439
[TBL] [Abstract][Full Text] [Related]
27. Incidence, Treatment, and Survival in Primary Central Nervous System Neuroblastoma.
Lu X; Zhang X; Deng X; Yang Z; Shen X; Sheng H; Yin B; Zhang N; Lin J
World Neurosurg; 2020 Aug; 140():e61-e72. PubMed ID: 32344130
[TBL] [Abstract][Full Text] [Related]
28. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
Jemal A; Ward E; Thun MJ
Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
[TBL] [Abstract][Full Text] [Related]
29. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
[TBL] [Abstract][Full Text] [Related]
30. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
[TBL] [Abstract][Full Text] [Related]
32. Neuroblastoma in adults: Incidence and survival analysis based on SEER data.
Esiashvili N; Goodman M; Ward K; Marcus RB; Johnstone PA
Pediatr Blood Cancer; 2007 Jul; 49(1):41-6. PubMed ID: 16628557
[TBL] [Abstract][Full Text] [Related]
33. Effects of mass screening on age-specific incidence of neuroblastoma.
Bessho F
Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
[TBL] [Abstract][Full Text] [Related]
34. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.
Chen AY; Jemal A; Ward EM
Cancer; 2009 Aug; 115(16):3801-7. PubMed ID: 19598221
[TBL] [Abstract][Full Text] [Related]
35. Cancer incidence and survival trends among infants in the United States from 1975 to 2014.
Wang H; Mejia MC; Gonzalez SJ; Zoorob RJ; Chai W; Du XL
Pediatr Blood Cancer; 2021 Apr; 68(4):e28917. PubMed ID: 33470510
[TBL] [Abstract][Full Text] [Related]
36. Trends in childhood cancer incidence and mortality in urban Shanghai, 1973-2005.
Bao PP; Zheng Y; Gu K; Wang CF; Wu CX; Jin F; Lu W
Pediatr Blood Cancer; 2010 Jul; 54(7):1009-13. PubMed ID: 20052777
[TBL] [Abstract][Full Text] [Related]
37. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
[TBL] [Abstract][Full Text] [Related]
38. Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population.
Bates JE; Peterson CR; Dhakal S; Giampoli EJ; Constine LS
Pediatr Blood Cancer; 2014 Nov; 61(11):1955-60. PubMed ID: 25130403
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
Carlsen NL
Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
[TBL] [Abstract][Full Text] [Related]
40. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
